Redeye updates estimates and valuation on EG7 ahead of its Q1-results (due May 25) where we expected...
Sales -3% vs. ABGSCe Adj. EBITDA 14% vs. ABGSCe We expect cons.
Redeye comments on Urb-it’s Q1 report, which showed revenue growth of 124% Y/Y but well below our ex...
Redeye sees a solid Q1 report from Vertiseit, with stronger sales and EBIT than we expected.
Redeye comments on Evolution’s Q1-results that came in slightly above our expectations.
Sales -11% vs ABGSCe (SEK 10.9m vs ABGSCe 12.3m) As we expected, Q1 came in seasonally softer… … but...
CapMan reported Q1 EBIT of 18.9m, 244% above Infront consensus.
NOI +5% vs ABGSCe and +4% vs cons. Like-for-like rental income +3.
Massive estimate revisions High activity expected in Q1 Discounts oil price of ~USD 70/bbl Higher o...
Sales up 19% y-o-y, solid growth in all three segments Sales estimates up slightly, but we reduce ‘2...
Volumes to begin ramping up in newly added foundries ’22 and ’24 series production targets reiterate...
A strong start to FY’22, as expected ‘22e-‘24e adj.
Malmbergs Elektriska redovisade tillväxt under det första kvartalet men resultatmässigt blev utfalle...
Kraftig tillväxt Beijer Almas omsättning växte med 33% y/y till 1 704 mkr i Q1.
Q1 sales growth of 15% y-o-y, albeit lower EBIT Range of estimate adjustments, long-term EBIT -1% Wo...
-16% organic growth on another weak Americas quarter Turning point in Q2, growth in H2 EBIT estimate...
Organic growth of 21% (ABGSCe 6%) Adj. EBITA slighly weaker than expected on cost inflation Estimate...
Redeye will likely raise its short-term cost forecasts slightly while leaving long-term margin assum...
Redeye has a positive take on Sleep Cycle's robust underlying growth.
En viktig hörnsten i SDS:s organiska tillväxt är att växa med sina kunder genom att ta sig in på nya...
